- Report
- March 2025
- 95 Pages
France
From €5456EUR$5,995USD£4,677GBP
- Report
- March 2025
- 97 Pages
United Kingdom
From €5456EUR$5,995USD£4,677GBP
- Report
- March 2025
- 149 Pages
United States
From €5456EUR$5,995USD£4,677GBP
- Report
- February 2025
- 36 Pages
Brazil
From €4546EUR$4,995USD£3,897GBP
- Report
- February 2025
- 36 Pages
Mexico
From €4546EUR$4,995USD£3,897GBP
- Report
- February 2025
- 36 Pages
Japan
From €4546EUR$4,995USD£3,897GBP
- Report
- February 2025
- 36 Pages
China
From €4546EUR$4,995USD£3,897GBP
- Report
- February 2025
- 36 Pages
South Korea
From €4546EUR$4,995USD£3,897GBP
- Report
- February 2025
- 36 Pages
Russia
From €4546EUR$4,995USD£3,897GBP
- Report
- February 2025
- 36 Pages
Spain
From €4546EUR$4,995USD£3,897GBP
- Report
- February 2025
- 36 Pages
Italy
From €4546EUR$4,995USD£3,897GBP
- Report
- February 2025
- 36 Pages
France
From €4546EUR$4,995USD£3,897GBP
- Report
- February 2025
- 36 Pages
United Kingdom
From €4546EUR$4,995USD£3,897GBP
- Report
- February 2025
- 34 Pages
United States
From €4546EUR$4,995USD£3,897GBP
- Report
- March 2025
- 89 Pages
Russia
From €5456EUR$5,995USD£4,677GBP

The Urethral Stent market is a subset of the larger Stent market. Urethral Stents are medical devices used to treat urethral strictures, a condition in which the urethra becomes narrowed due to scarring or other causes. Urethral Stents are typically made of a biocompatible material such as nitinol, stainless steel, or polyurethane, and are inserted into the urethra to keep it open. Urethral Stents are typically used in combination with other treatments such as dilation or urethrotomy.
Urethral Stents are used in a variety of medical settings, including urology, oncology, and general surgery. They are used to treat a variety of conditions, including urethral strictures, urethral trauma, and urethral cancer.
Some companies in the Urethral Stent market include Boston Scientific, Cook Medical, and Coloplast. Show Less Read more